AIM ImmunoTech Inc. Revenue 2009–2025
AIM ImmunoTech Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- AIM ImmunoTech Inc. revenue for the quarter ending March 31, 2026 was 22000, a 37.50% increase year-over-year.
- AIM ImmunoTech Inc. revenue for the twelve months ending March 31, 2026 was 89000, a 47.95% decrease year-over-year.
- AIM ImmunoTech Inc. annual revenue for 2025 was 88000, a 48.24% decrease from 2024.
- AIM ImmunoTech Inc. annual revenue for 2024 was 170000, a 15.84% decrease from 2023.
- AIM ImmunoTech Inc. annual revenue for 2023 was 202000, a 43.26% increase from 2022.
- AIM ImmunoTech Inc. annual revenue for 2022 was 141000.
AIM ImmunoTech Inc. (AIM) — Frequently Asked Questions
AIM ImmunoTech Inc. (AIM) is a publicly traded US company. It has a market capitalization of $744,401.942. In fiscal 2025 it reported revenue of $88,000 and net income of -$14M. Explore AIM's stock price, financial statements, earnings history, margins and key ratios below.
What is AIM ImmunoTech Inc.'s market cap?
AIM ImmunoTech Inc. (AIM) has a market capitalization of $744,401.942.
What is the AIM stock price?
AIM trades at $0.46 (+4.52% on the day).
How much revenue does AIM ImmunoTech Inc. make?
AIM ImmunoTech Inc. reported revenue of $88,000 in fiscal 2025.
Is AIM profitable?
In fiscal 2025, AIM ImmunoTech Inc. reported net income of -$14M.